Fig. 1: Available SARS-CoV-2 genomic sequencing data and its usage for outbreak investigation.
From: Unlocking capacities of genomics for the COVID-19 response and future pandemics
a, The number of SARS-CoV-2 genomes sequenced in different regions according to Global Initiative On Sharing All Influenza Data (GISAID) between January 2020 and December 2021. b, The number of available SARS-CoV-2 sequences in GISAID per 1 million (1M) individuals vs. the number of cases per capita for each country or region up to March 2021. c, The number of available SARS-CoV-2 sequences in GISAID per 1M individuals vs. the number of sequencers per capita for each country in Africa up to March 2021. Blue line is the correlation of all data points on the plot. d, The number of available SARS-CoV-2 sequences in GISAID per number of reported COVID-19 cases vs. the number of reported COVID-19 cases per capita for each country or region from December 2019 up to December 2021. e, Global outbreak investigations by phylogenetic analysis (red) and wastewater studies (yellow); dots are placed in the geographical centers of each country or region.
